IL17A and early-onset autosomal dominant Alzheimer disease: The KEGG enrichment analysis results showed that Osteoking mainly acts on LDH through pathways in cancer, Alzheimer disease, microRNAs in cancer, IL-17 signalling pathway and other pathways (Fig. 4).